Analysts Anticipate Omeros to Post ($0.64) Earnings Per Share (NASDAQ:OMER)

Omeros (NASDAQ:OMER) has been given a consensus broker rating score of 1.50 (Hold) from the two analysts that provide coverage for the company, Zacks Investment Research reports. One analyst has rated the stock with a buy recommendation and one has issued a strong buy recommendation on the company.

Analysts have set a 12-month consensus price target of $34.50 for the company and are predicting that the company will post ($0.64) EPS for the current quarter, according to Zacks. Zacks has also assigned Omeros an industry rank of 98 out of 265 based on the ratings given to its competitors.

Several analysts have recently commented on the stock. Analysts at Maxim Group raised their price target on shares of Omeros from $20.00 to $28.00 in a research note on Thursday, November 13th. They now have a “buy” rating on the stock. Analysts at Needham & Company LLC set a $22.00 price target on shares of Omeros in a research note on Friday, October 31st.

Shares of Omeros (NASDAQ:OMER) opened at 24.78 on Friday. Omeros has a 1-year low of $9.76 and a 1-year high of $25.10. The stock’s 50-day moving average is $21.92 and its 200-day moving average is $16.07. The company’s market cap is $844.4 million.

Omeros (NASDAQ:OMER) last posted its quarterly earnings results on Monday, November 10th. The company reported ($0.54) EPS for the quarter, beating the Thomson Reuters consensus estimate of ($0.59) by $0.05. The company had revenue of $0.21 million for the quarter, compared to the consensus estimate of $0.43 million. During the same quarter in the prior year, the company posted ($0.46) earnings per share. The company’s quarterly revenue was up 9.2% on a year-over-year basis. Analysts expect that Omeros will post $-2.15 EPS for the current fiscal year.

Omeros Corporation operates as a biopharmaceutical company focused on the discovery, development and commercialization of products focused on inflammation and disorders of the central nervous system.

To get a free copy of the research report on Omeros (OMER), click here. For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Omeros Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Omeros and related companies with Analyst Ratings Network's FREE daily email newsletter.

Latest News

Instacart the Grocery Delivery Startup Raises $210 Million
Instacart the Grocery Delivery Startup Raises $210 Million
China Will Relax Regulations on Banks Renminbi Trading
China Will Relax Regulations on Banks Renminbi Trading
Subway in Safety Scandal in China over Food
Subway in Safety Scandal in China over Food
UPS and FedEx Make Improvements During Holiday Season
UPS and FedEx Make Improvements During Holiday Season
MasterCard Spending Report for Holidays Shows Weak Electronics
MasterCard Spending Report for Holidays Shows Weak Electronics
Gift Cards Have Become Hugely Popular, but Have Risks
Gift Cards Have Become Hugely Popular, but Have Risks


Leave a Reply

Advertisement
Advertisement
© 2006-2015 Leoncheng.